Efficacy and Satisfaction of Low Doses UVA1 Phototherapy: A Spanish Experience from a Single Centre
Abstract
:1. Introduction
2. Materials and Methods
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Prasad, S.A.; Coias, J.; Chen, H.W.; Jacobe, H. Utilizing UVA-1 Phototherapy. Dermatol. Clin. 2020, 38, 79–90. [Google Scholar] [CrossRef] [PubMed]
- Pitney, T.; Pitney, M.J. A retrospective review of UVA1 treatment: An Australian experience from a single centre. Australas. J. Dermatol. 2020, 61, 318–323. [Google Scholar] [CrossRef] [PubMed]
- Tuchinda, C.; Kerr, H.A.; Taylor, C.R.; Jacobe, H.; Bergamo, B.M.; Elmets, C.; Rivard, J.; Lim, H.W. UVA1 phototherapy for cutaneous diseases: An experience of 92 cases in the United States. Photodermatol. Photoimmunol. Photomed. 2006, 22, 247–253. [Google Scholar] [CrossRef] [PubMed]
- Gambichler, T.; Terras, S.; Kreuter, A. Treatment regimens, protocols, dosage, and indications for UVA1 phototherapy: Facts and controversies. Clin. Dermatol. 2013, 31, 438–454. [Google Scholar] [CrossRef] [PubMed]
- Yamauchi, R.; Morita, A.; Yasuda, Y.; Grether-Beck, S.; Klotz, L.-O.; Tsuji, T.; Krutmann, J. Different Susceptibility of Malignant versus Nonmalignant Human T Cells toward Ultraviolet A-1 Radiation-Induced Apoptosis. J. Investig. Dermatol. 2004, 122, 477–483. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Gambichler, T.; Skrygan, M.; Tomi, N.S.; Breuksch, S.; Altmeyer, P.; Kreuter, A. Significant downregulation of transforming growth factor-beta signal transducers in human skin following ultraviolet-A1 irradiation. Br. J. Dermatol. 2007, 156, 951. [Google Scholar] [CrossRef]
- Kroft, E.B.; Berkhof, N.J.; van de Kerkhof, P.C.; Gerritsen, R.M.; de Jong, E.M. Ultraviolet A phototherapy for sclerotic skin diseases: A systematic review. J. Am. Acad. Dermatol. 2008, 59, 1017–1030. [Google Scholar] [CrossRef]
- Tognetti, L.; Marrocco, C.; Carraro, A.; Guerrini, G.; Mariotti, G.; Cinotti, E.; Rubegni, P. Clinical and laboratory characterization of patients with localized scleroderma and response to UVA -1 phototherapy: In vivo and in vitro skin models. Photodermatol. Photoimmunol. Photomed. 2022, 38, 531–540. [Google Scholar] [CrossRef]
- Gambichler, T.; Schmitz, L. Ultraviolet A1 Phototherapy for Fibrosing Conditions. Front. Med. 2018, 5, 237. [Google Scholar] [CrossRef]
- Connolly, K.; Griffith, J.L.; McEvoy, M.T.; Lim, H.W. Ultraviolet A1 phototherapy beyond morphea: Experience in 83 patients. Photodermatol. Photoimmunol. Photomed. 2015, 31, 289–295. [Google Scholar] [CrossRef]
- Stege, H.; Berneburg, M.; Humke, S.; Klammer, M.; Grewe, M.; Grether-Beck, S.; Boedeker, R.; Diepgen, T.; Dierks, K.; Goerz, G.; et al. High-dose UVA1 radiation therapy for localized scleroderma. J. Am. Acad. Dermatol. 1997, 36, 938–944. [Google Scholar] [CrossRef]
- Furuhashi, T.; Torii, K.; Ikumi, K.; Kato, H.; Nishida, E.; Morita, A. Ultraviolet A1 phototherapy for the treatment of localized scleroderma. J. Dermatol. 2020, 47, 792–795. [Google Scholar] [CrossRef]
- Zhu, J.L.; Black, S.M.; Chen, H.W.; Jacobe, H.T. Emerging treatments for scleroderma/systemic sclerosis. Fac. Rev. 2021, 10, 43. [Google Scholar] [CrossRef]
- El-Mofty, M.; Mostafa, W.; El-Darouty, M.; Bosseila, M.; Nada, H.; Yousef, R.; Esmat, S.; El-Lawindy, M.; Assaf, M.; El-Enani, G. Different low doses of broad-band UVA in the treatment of morphea and systemic sclerosis. A clinico-pathologic study. Photodermatol. Photoimmunol. Photomed. 2004, 20, 148–156. [Google Scholar] [CrossRef]
- Durand, F.; Staumont, D.; Bonnevalle, A.; Hachulla, E.; Hatron, P.-Y.; Thomas, P. Ultraviolet A1 phototherapy for treatment of acrosclerosis in systemic sclerosis: Controlled study with half-side comparison analysis. Photodermatol. Photoimmunol. Photomed. 2007, 23, 215–221. [Google Scholar] [CrossRef]
- Kreuter, A.; Breuckmann, F.; Uhle, A.; Brockmeyer, N.; von Kobyletzki, G.; Freitag, M.; Stuecker, M.; Hoffmann, K.; Gambichler, T.; Altmeyer, P. Low-dose UVA1 phototherapy in systemic sclerosis: Effects on acrosclerosis. J. Am. Acad. Dermatol. 2004, 50, 740–747. [Google Scholar] [CrossRef]
- Rose, R.F.; Turner, D.; Goodfield, M.J.D.; Goulden, V. Low-dose UVA1 pho- totherapy for proximal and acral scleroderma in systemic sclerosis. Photodermatol. Photoimmunol. Photomed. 2009, 25, 153–155. [Google Scholar] [CrossRef]
- Kreuter, A.; Gambichler, T.; Avermaete, A.; Happe, M.; Bacharach-Buhles, M.; Hoffmann, K.; Jansen, T.; Altmeyer, P.; von Kobyletzki, G. Low-dose ultraviolet A1 phototherapy for extragenital lichen sclerosus: Results of a preliminary study. J. Am. Acad. Dermatol. 2002, 46, 251–255. [Google Scholar] [CrossRef]
- Linares-González, L.; Ródenas-Herranz, T.; Espelt-Otero, J.; Ruiz-Villaverde, R. Escleredema de Buschke refractario a terapia convencional. Respuesta a UVA1. Actas Dermosifiliogr. 2021, 112, 466–468. [Google Scholar] [CrossRef]
- Janiga, J.J.; Ward, D.H.; Lim, H.W. UVA-1 as a treatment for scleredema. Photodermatol. Photoimmunol. Photomed. 2004, 20, 210–211. [Google Scholar] [CrossRef]
- Kochs, C.; Bockmann, A.; Hanneken, S.; Neumann, N.J. Scleredema diabeticorum: Successful treatment with UVA-1 phototherapy. Hautarzt 2011, 62, 255–257. [Google Scholar] [CrossRef] [PubMed]
- Thumpimukvatana, N.; Wongpraparut, C.; Lim, H.W. Scleredema diabeticorum successfully treated with ultraviolet A1 phototherapy. J. Dermatol. 2010, 37, 1036–1039. [Google Scholar] [CrossRef] [PubMed]
- Kroft, E.B.M.; de Jong, E.M.G.J. Scleredema Diabeticorum Case Series: Successful Treatment With UV-A1. Arch. Dermatol. 2008, 144, 947–948. [Google Scholar] [CrossRef] [PubMed]
- Hannuksela-Svahn, A.; Grandal, O.J.; Thorstensen, T.; Christensen, O.B. UVA1 for treatment of keloids. Acta Derm. Venereol. 1999, 79, 490. [Google Scholar] [CrossRef]
- Cuenca-Barrales, C.; Aneiros-Fernández, J.; Pérez-López, I.; Rodríguez-Pérez, J.; Ruiz-Villaverde, R.; Espelt-Otero, J.L. Histological Changes Related to Symptomatic Improvement of Spontaneous Keloids Treated with a Low-Dosage Regimen of UVA-1 Phototherapy. Dermatopathology 2020, 7, 53–56. [Google Scholar] [CrossRef]
- Sidbury, R.; Davis, D.M.; Cohen, D.E.; Cordoro, K.M.; Berger, T.G.; Bergman, J.N.; Chamlin, S.L.; Cohen, D.E.; Cooper, K.D. Guidelines of care for the management of atopic dermatitis: Section Management and treatment with phototherapy and systemic agents. J. Am. Acad. Dermatol. 2014, 71, 327–349. [Google Scholar] [CrossRef] [Green Version]
- Ordóñez Rubiano, M.F.; Arenas, C.M.; Chalela, J.G. UVA-1 phototherapy for the management of atopic dermatitis: A large retrospective study conducted in a low-middle income country. Int. J. Dermatol. 2018, 57, 799–803. [Google Scholar] [CrossRef]
- Musters, A.H.; Mashayekhi, S.; Flohr, C.; Drucker, A.M.; Gerbens, L.; Ferguson, J.; Ibbotson, S.; Dawe, R.S. Phototherapy for atopic eczema. Cochrane Libr. 2021, 10, CD013870. [Google Scholar]
- Pérez-Ferriols, A.; Aranegui, B.; Pujol-Montcusí, J.; Martín-Gorgojo, A.; Campos-Domínguez, M.; Feltes, R.; Gilaberte, Y.; Echeverría-García, B.; Alvarez-Pérez, A.; García-Doval, I. Phototherapy in Atopic Dermatitis: A Systematic Review of the Literature. Actas Dermosifiliogr. 2015, 106, 387–401. [Google Scholar] [CrossRef]
- Meduri, N.B.; Vandergriff, T.; Rasmussen, H.; Jacobe, H. Phototherapy in the management of atopic dermatitis: A systematic review. Photodermatol. Photoimmunol. Photomed. 2007, 23, 106–112. [Google Scholar] [CrossRef]
- Malinowska, K.; Woźniacka, A.; Bogaczewicz, J. The impact of medium dose UVA1 phototherapy on pruritus, DLQI and SCORAD index in patients with atopic dermatitis. Adv. Dermatol. Allergol. 2020, 37, 962–967. [Google Scholar] [CrossRef]
- Olsen, E.A.; Hodak, E.; Anderson, T.; Carter, J.B.; Henderson, M.; Cooper, K.; Lim, H.W. Guidelines for phototherapy of mycosis fungoides and Sézary syndrome: A consensus statement of the United States Cutaneous Lymphoma Consortium. J. Am. Acad. Dermatol. 2016, 74, 27–58. [Google Scholar] [CrossRef]
- Adışen, E.; Tektaş, V.; Erduran, F.; Erdem, Ö.; Gürer, M.A. Ultraviolet A1 Phototherapy in the Treatment of Early Mycosis Fungoides. Dermatology 2017, 233, 192–198. [Google Scholar] [CrossRef] [Green Version]
- Jang, M.S.; Kang, D.Y.; Jeon, Y.S.; Kim, S.T.; Suh, K.S. Ultraviolet A1 Phototherapy of Mycosis Fungoides. Ann. Dermatol. 2013, 25, 104–107. [Google Scholar] [CrossRef]
- Joshi, T.P.; Duvic, M. Granuloma Annulare: An Updated Review of Epidemiology, Pathogenesis, and Treatment Options. Am. J. Clin. Dermatol. 2021, 23, 37–50. [Google Scholar] [CrossRef]
- Nordmann, T.M.; Kim, J.-R.; Dummer, R.; Anzengruber, F. A Monocentric, Retrospective Analysis of 61 Patients with Generalized Granuloma Annulare. Dermatology 2020, 236, 369–374. [Google Scholar] [CrossRef]
- Aichelburg, M.; Pinkowicz, A.; Schuster, C.; Volc-Platzer, B.; Tanew, A. Patch granuloma annulare: Clinicopathological characteristics and response to phototherapy. Br. J. Dermatol. 2019, 181, 198–199. [Google Scholar] [CrossRef] [Green Version]
- Mukovozov, I.M.; Kashetsky, N.; Richer, V. Light- and laser-based treatments for granuloma annulare: A systematic review. Photodermatol. Photoimmunol. Photomed. 2022, 38, 301–310. [Google Scholar] [CrossRef]
- Gobello, T.; Mazzanti, C.; Sordi, D.; Annessi, G.; Abeni, D.; Chinni, L.M.; Girolomoni, G. Medium- versus high-dose ultraviolet A1 therapy for urticaria pigmentosa: A pilot study. J. Am. Acad. Dermatol. 2003, 49, 679–684. [Google Scholar] [CrossRef]
- Stege, H.; Schöpf, E.; Ruzicka, T.; Krutmann, J. High-dose UVA1 for urticaria pigmentosa. Lancet 1996, 347, 64. [Google Scholar] [CrossRef]
- Von Kobyletzki, G.; Kreuter, J.A.; Nordmeier, R.; Stücker, M.; Altmeyer, P. Treatment of idiopathic mucinosis follicularis with UVA1 cold light phototherapy. Dermatology 2000, 201, 76–77. [Google Scholar] [CrossRef] [PubMed]
- Arrieta, A.; Jaka, A.; del Alcázar, E.; Blanco, M.; Carrascosa, J.M. Fototerapia en el prurigo nodular. Experiencia propia y revisión de la literatura. Actas Dermosifiliogr. 2021, 112, 339–344. [Google Scholar] [CrossRef] [PubMed]
- Rombold, S.; Lobisch, K.; Katzer, K.; Grazziotin, T.C.; Ring, J.; Eberlein, B. Efficacy of UVA1 phototherapy in 230 patients with various skin diseases. Photodermatol. Photoimmunol. Photomed. 2008, 24, 19–23. [Google Scholar] [CrossRef] [PubMed]
- Bruni, E.; Caccialanza, M.; Piccinno, R. Phototherapy of generalized prurigo nodularis. Clin. Exp. Dermatol. 2009, 35, 549–550. [Google Scholar] [CrossRef]
- Schmidtt, A. UVA1 irradiation is effective in treatment of chronic vesicular dyshidrotic hand eczema. Acta Derm Venereol. 1998, 78, 318–319. [Google Scholar]
- Polderman, M.C.A.; Govaert, J.C.M.; le Cessie, S.; Pavel, S. A double-blind placebo-controlled trial of UVA-1 in the treatment of dyshidrotic eczema: UVA-1 for dyshidrotic eczema. Clin. Exp. Dermatol. 2003, 28, 584–587. [Google Scholar] [CrossRef] [Green Version]
- Petering, H.; Breuer, C.; Herbst, R.; Kapp, A.; Werfel, T. Comparison of localized high-dose UVA1 irradiation versus topical cream psoralen-UVA for treatment of chronic vesicular dyshidrotic eczema. J. Am. Acad. Dermatol. 2004, 50, 68–72. [Google Scholar] [CrossRef]
- Raap, U.; Kenneweg, C.; Kapp, A.; Werfel, T. Neue und seltener angewandte Therapieoptionen bei therapie refraktaärem Handekzem. Hautarzt 2008, 59, 710–716. [Google Scholar] [CrossRef]
Diagnosis | Patients | Sex (Male/Female) | Median Age (Range) | Range Sessions per Cycle | Median Total Joules (Range) | Response Complete (>95%) | Response Partial (>50%) | No Response | Median TSQM (Range) | Adverse Effects |
---|---|---|---|---|---|---|---|---|---|---|
Morphea | 13 | 2/11 | 56 (18–76) | 17–60 | 321 (111–632) | 6 (46.15%) | 7 (53.85%) | 0 (0%) | 68 (41–72) | Two patients tanning |
Diffuse systemic sclerosis | 6 | 0/6 | 57 (48–81) | 10–35 | 449 (214–1529) | 1 (16.67%) | 5 (83.33% | 0 (0%) | 65,5 (60–72) | Not referred |
Limited systemic sclerosis | 2 | 0/2 | 57.5 (42–73) | 20–35 | 377 (323–431) | 1 (50%) | 1 (50%) | 0 (0%) | 68 (66–71) | No referred |
Extragenital lichen sclerosus | 2 | 0/2 | 69 (62–76) | 30 | 470 (330–610) | 0 (0%) | 2 (100%) | 0 (0%) | 60.5 (56–65) | One patient tanning |
Scleredema | 2 | 1/1 | 59.5 (55–64) | 25–30 | 619 (108–1130) | 2 (100%) | 0 (0%) | 0 (0%) | 70.5 (69–72) | No referred |
Keloids | 5 | 2/3 | 36 (25–57) | 10–30 | 331 (47–714) | 0 (0%) | 3 (60%) | 2 (40%) | 51 (41–67) | No referred |
Atopic dermatitis | 2 | 0/2 | 36.5 (23–50) | 20–25 | 333 (229–437) | 0 (0%) | 2 (100%) | 0 (0%) | 53 (45–61) | One patient skin xerosis |
Chronic hand eczema | 5 | 2/3 | 54 (23–69) | 30 | 753 (513–805) | 2 (40%) | 1 (20%) | 2 (40%) | 67 (41–72) | No referred |
Prurigo nodularis | 1 | 0/1 | 67 | 25 | 554 | 1 (100%) | 0 (0%) | 0 (0%) | 68 | No referred |
Mycosis fungoides | 4 | 3/1 | 49 (24–51) | 30–40 | 853 (567–1679) | 1 (25%) | 3 (75%) | 0 (0%) | 61.5 (48–71) | One patient skin xerosis and transient erythema |
Granuloma annulare | 2 | 0/2 | 64.5 (57–72) | 20–25 | 158 (118–198) | 2 (100%) | 0 (0%) | 0 (0%) | 58 (51–65) | No referred |
Mastocytosis | 1 | 0/1 | 40 | 30 | 1686 | 0 (0%) | 1 (100%) | 0 (0%) | 71 | No referred |
Mucinosis follicularis | 1 | 0/1 | 59 | 30 | 510 | 1 (100%) | 0 (0%) | 0 (0%) | 58 | No referred |
TOTAL | 46 | 10/36 | 55 (18–81) | 17 (36.96%) | 25 (54.34%) | 4 (8.70%) | 65 (41–72) |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Velasco-Amador, J.P.; Linares-Gonzalez, L.; De la Torre-Gomar, F.J. Efficacy and Satisfaction of Low Doses UVA1 Phototherapy: A Spanish Experience from a Single Centre. Life 2023, 13, 669. https://doi.org/10.3390/life13030669
Velasco-Amador JP, Linares-Gonzalez L, De la Torre-Gomar FJ. Efficacy and Satisfaction of Low Doses UVA1 Phototherapy: A Spanish Experience from a Single Centre. Life. 2023; 13(3):669. https://doi.org/10.3390/life13030669
Chicago/Turabian StyleVelasco-Amador, Juan Pablo, Laura Linares-Gonzalez, and Francisco Javier De la Torre-Gomar. 2023. "Efficacy and Satisfaction of Low Doses UVA1 Phototherapy: A Spanish Experience from a Single Centre" Life 13, no. 3: 669. https://doi.org/10.3390/life13030669